Mark E Strome bought $195k of ZIVO
owner at Zivo Bioscience, Inc.. 20,000 shares at an average of $9.77, traded Feb 12, 2026, filed Feb 17, 2026.
Score components
- +12Role10% owner
- +12Trade size$195k at market
- 0Relative to holdingsHoldings up 4.4%
- +8Price context54% below the 52-week high
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
- -5Outside holderA 10% owner who is not an officer or director
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -7.0%, 3m -59.4%, 6m -59.5%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001213900-26-016803, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 12, 2026 | POpen-market purchase Common Stockindirect: By entity | +20,000 | $9.77 | $195k | 472,942 | Feb 17, 2026 |
| Feb 12, 2026 | POpen-market purchase Common Stock Purchase Warrantderivativeindirect: By entity | +2,000 | $0.00 | $0 | 45,071 | Feb 17, 2026 |
Related signals
Other insiders at Zivo Bioscience, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 43Moderate | ZIVObuy Zivo Bioscience, Inc. | Mark E Strome owner | $200k 100,000 shares | +21% | |
| 23Weak | ZIVObuy Zivo Bioscience, Inc. | Laith L Yaldoo director, owner | $15k 1,543 shares | +0% | |
| 31Weak | Zivo Bioscience, Inc. | Laith L Yaldoo director, owner | $25k 2,434 shares | +0% | |
| 48Moderate | Zivo Bioscience, Inc. | Alison A Cornell director | $100k 11,709 shares | +4% | |
| 68Notable | Zivo Bioscience, Inc. | John Bernard Payne President and CEO | $100k 11,709 shares | +148% | |
| 33Weak | Zivo Bioscience, Inc. | Christopher D. Maggiore director, owner | $15k 1,766 shares | +0% | |
| 38Weak | Zivo Bioscience, Inc. | Laith L Yaldoo director, owner | $15k 1,766 shares | +0% | |
| 23Weak | ZIVObuy Zivo Bioscience, Inc. | Laith L Yaldoo director, owner | $25k 2,777 shares | +0% | |
| 43Moderate | Zivo Bioscience, Inc. | Mark E Strome owner | $250k 20,259 shares | +5% | |
| 38Weak | Zivo Bioscience, Inc. | Laith L Yaldoo director, owner | $20k 1,659 shares | +0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.